Screening children for early signs of type 1 diabetes
Part of Hormones & metabolism clinical trials.
This study checks for specific blood markers (“islet autoantibodies”) to find children who may be at risk for developing type 1 diabetes later, before symptoms start. It’s mainly for children who have no known diabetes yet.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You (and your child, when possible) must give informed consent before any study steps.
- Your child must be between 9 months and 5 years old at the first screening.
- Your child must not already have a known diagnosis of diabetes (type 1 or any other type).
- You must be willing to take part in the screening process as explained by the study team.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study screens close family members of people with type 1 diabetes for early signs of the condition. A simple blood test looks for special markers (autoantibodies) that can show if the immune system is starting to attack the pancreas. Finding these markers early may help doctors prevent or delay the onset of diabetes.
This study screens children aged 2 to 10 for early signs of type 1 diabetes using a simple blood test. Finding these signs early may help prevent or delay the disease.
This trial is looking for children with newly diagnosed type 1 diabetes to study how to detect the condition earlier. It focuses on kids who have already reached the stage where symptoms appear, to improve understanding of the disease.
This study screens newborn babies (up to 6 weeks old) to identify those at high risk for type 1 diabetes, so they can be invited to join future prevention trials. The goal is to catch risk early and potentially prevent the disease.
This study follows children who are at genetic risk for type 1 diabetes or have early immune signs (autoantibodies) but do not yet need insulin. It provides extra checkups and information to catch the disease early and help families understand their child's risk.
This study looks at infants to find how likely they are to develop type 1 diabetes later in life. If you have a newborn who is very young, you may be able to take part by allowing the study team to test them as part of early risk screening.
Hear when a new Type1diabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.